Sort
326,823 grants matching “clinical trial”
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
$2,768,492Sally Lynn Hodder · West Virginia University · U24 · FY2025 · GM
Injectable naltrexone 2-month depot formulations
$2,768,235Kinam Park · Purdue University · UH3 · FY2024 · DA
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
$2,768,137Sally Lynn Hodder · West Virginia University · U24 · FY2024 · GM
DCTD Computer Support
$2,767,982David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Assay Work for Yellow Fever Vaccines - VTEU
$2,767,600Marcelo Sztein · University Of Maryland Baltimore · N01 · FY2015 · AI
Regulatory Support for Cancer Prevention Agent Development
$2,767,550Caroline Sigman · Ccs Associates, Inc. · N02 · FY2020 · CA
Interdisciplinary Comprehensive Arm Rehab Evaluation (I-CARE) Stroke
$2,767,463Carolee J Winstein · University Of Southern California · U01 · FY2009 · NS
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,767,364Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
UCLA Center for AIDS Research (CFAR)
$2,767,328Jerome A. Zack · University Of California Los Angeles · P30 · FY2014 · AI
Administrative Core
$2,766,916Vincent Mor · Brown University · U54 · FY2019 · AG
Environmental Signaling in Reproduction and Pregnancy
$2,766,820Francesco Demayo · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,766,645University Of Washington · U01 · FY2002 · HL
ctsa infrastructure for pediatric research
$2,766,404Robert M Califf · Duke University · UL1 · FY2010 · RR
MALARIA: CLINICAL RESEARCH AND TRIAL PREPARATION SITES
$2,765,994University Of Maryland Baltimore · N01 · FY2000 · AI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,765,815Robert Stanley Sherwin · Yale University · UL1 · FY2010 · RR
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,765,551Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
ECOG Statistical Office Data Management Grant
$2,764,934Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2004 · CA
The Challenge of Individualizing Treatments for Patients with Breast Cancer
$2,764,196Steven J. Katz · University Of Michigan At Ann Arbor · P01 · FY2013 · CA
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
$2,764,135Peter G Stock · University Of California, San Francisco · U01 · FY2019 · AI
BIOSTATISTICS DATA MANAGEMENT CENTER FOR ACRIN
$2,764,100Brown University · U01 · FY2003 · CA
Comprehensive Cancer Center Program at Fox Chase
$2,763,834Richard I Fisher · Research Inst Of Fox Chase Can Ctr · P30 · FY2017 · CA
Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder
$2,763,621Christian Arthur Heidbreder · Indivior, Inc. · UG3 · FY2020 · DA
Pediatric Eye Disease Investigator Group Coordinating Center
$2,763,504Raymond Kraker · Jaeb Center For Health Research, Inc. · U10 · FY2014 · EY
Development of a Vaccine for HIV-AIDS: Humoral Immunity
$2,762,142Marjorie Guroff · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$2,761,944Alexander Pletnev · Niaid Extramural Activities · Z01 · FY2007 · AI